|
|
 Home > Conference Presentations
Conference Presentations
NCI Thyroid Fine Needle Aspiration State of the Science Conference
Click on the links to view the presentations. Conference Organizer:
Andrea Abati, M.D.
Chief, Cytopathology Section
National Cancer Institute/National Institutes of Health
Conference Moderators:
Edmund S. Cibas, M.D.
Director of Cytopathology (Brigham and Women's Hospital)
Associate Professor of Pathology (Harvard Medical School)
Department of Pathology
Brigham and Women's Hospital
Susan J. Mandel, M.D., M.P.H.
Associate Professor of Medicine and Radiology
University of Pennsylvania School of Medicine
Associate Chief for Clinical Affairs
Division of Endocrinology, Diabetes, and Metabolism
Monday, October 22, 2007
|
| 8:00 - 8:10 |
Welcome and Introductions of Moderators and Committee Chairs
Andrea Abati, M.D. |
| 8:10 - 8:30 |
What are the indications for performing an FNA of a thyroid nodule discovered by palpation?
William C. Faquin, M.D., Ph.D |
| 8:30 - 8:50 |
What are the indications for performing an FNA of a thyroid nodule discovered by an imaging study?
William Dana Middleton, M.D, F.A.C.R. |
| 8:50 - 9:15 |
When should an FNA be performed using palpation for guidance?
Erik K. Alexander, M.D. |
| 9:15 - 9:40 |
When should an FNA be performed using ultrasound guidance?
Matthew White, M.D. |
| 9:40 - 9:50 |
If an informed consent form is used, what information should appear on the report?
William C. Faquin, M.D., Ph.D. |
| 9:50 - 10:00 |
What is the minimum clinical/laboratory information that should appear on a requisition form accompanying a thyroid FNA?
William C. Faquin, M.D., Ph.D.
|
| 10:00 - 10:30 |
BREAK
|
| 10:30 - 11:00 |
Review of training.
Britt-Marie Ljung, M.D. |
| 11:00 - 11:15 |
Training controversies from forum rounds 1 and 2
Britt-Marie Ljung, M.D. |
| 11:15 - 11:40 |
Discussion of training and controversies.
Britt-Marie Ljung, M.D. |
| 11:40 - 11:50 |
Review of credentialing and controversies.
Britt-Marie Ljung, M.D. |
| 11:50 - 12:00 |
Discussion of credentialing and controversies.
Britt-Marie Ljung, M.D. |
| 12:00-12:10 |
Introduction - Technique for thyroid FNA.
Martha Pitman, M.D. |
| 12:10-12:30 |
Aspiration devices, needles and methods for thyroid FNA.
John Abele, M.D.
|
| 12:30-1:30 |
LUNCH
|
| 1:30-2:00 |
Role and use of anesthesia for FNA of palpable and non-palpable nodules of the thyroid.
John Abele, M.D. |
| 2:00-3:00 |
Influence of nodule location, size and imaging characteristics on FNA technique.
Role of ultrasound guidance for FNA of palpable thyroid nodules.
The role of core needle biopsy for palpable and non-palpable thyroid nodules.
Advantages and disadvantages to various specialists performing FNA of palpable thyroid nodules. Dan Duick, M.D. |
| 3:00-3:30 |
Management of adverse reactions during and after thyroid FNA.
Gregory Randolph, M.D.
|
| 3:30-4:00 |
BREAK
|
| 4:00-4:30 |
Optimal preparation of FNA material for routine evaluation and ancillary studies, and the role of immediate assessment.
Optimal number of biopsy passes for solid and cystic nodules.
Sample adequacy for solid and cystic thyroid nodules.
Martha Pitman, M.D. |
| 4:30 - 5:00 |
Thyroid FNA Classification-benign thyroid lesions.
Zubair W. Baloch, M.D, Ph.D.
|
| Tuesday, October 23, 2007 |
| 8:00 - 8:20 |
Atypia in Thyroid.
Virginia A. LiVolsi, M.D. |
| 8:20 - 9:00 |
Thyroid FNA Classification - follicular patterned lesions.
Zubair W. Baloch, M.D., Ph.D. |
| 9:00 - 9:30 |
Thyroid FNA Classification - malignant thyroid lesions. (Baloch).
Thyroid FNA Classification - malignant thyroid lesions. (Asa)
Zubair W. Baloch, M.D., Ph.D.
Sylvia A. Asa, M.D. |
| 9:30 -10:00 |
Thyroid FNA Classification - Controversies: forum round 1.
Zubair Baloch, M.D., Ph.D.
|
| 10:00 - 10:30 |
BREAK
|
| 10:30 - 12:00 |
Thyroid FNA Classification - Controversies: forum round 2.
Zubair Baloch, M.D., Ph.D. |
| 12:00 - 12:30 |
Utilization of ancillary studies in thyroid FNA.
Doug Clark, M.D.
|
| 12:30 - 1:30 |
LUNCH
|
| 1:30 - 2:00 |
Indications for ancillary studies on thyroid FNAs. Specific studies to be performed for each of these indications.
Doug Clark, M.D. |
| 2:00 - 2:30 |
Sample preparation for each type of ancillary study.
Doug Clark, M.D. |
| 2:30 - 2:35 |
Post- FNA options.
Lester Layfield, M.D. |
| 2:35 - 3:05 |
Follow-up of non diagnostic FNA results.
Claire Michael, M.D. |
| 3:05 - 3:30 |
Follow-up of benign FNA results.
Hossein Gharib, M.D.
|
| 3:30 - 4:00 |
BREAK
|
| 4:00 - 4:30 |
Follow-up of indeterminate FNA results.
Jacki Abrams, M.D. |
| 4:30 - 4:55 |
Follow-up of malignant FNA results.
Helen Wang, M.D. |
| 4:55 - 5:00 |
Summation of post-FNA options
Lester Layfield, M.D. |
|
|
|